Brian Buggie, MD - SPRAVATO is the new FDA-approved esketamine nasal spray for treatment-resistant depression (TRD) in adults. It will be interesting to learn about its efficacy vs KETAMIND, the off-label nasal
Esketamine, New Depression Drug From Johnson & Johnson, Approved by FDA
FDA approves ketamine nasal spray to treat depression - CBS News
Ketamine Nasal Spray | Empower Pharmacy
Spravato vs. Ketamine | Ketamine Treatments
FDA approves depression nasal spray related to club drug ketamine | ClarksvilleNow.com
Ketamine - Town & Country Compounding
Study Finds Ketamine Nasal Spray Effective For Treating Depression: What You Should Know